Terms: = Prostate cancer AND NIN, KIAA1565, 51199, ENSG00000100503
6 results:
1. MiR-192 suppresses the tumorigenicity of prostate cancer cells by targeting and inhibiting nin one binding protein.
Sun J; Fan Z; Lu S; Yang J; Hao T; Huo Q
Int J Mol Med; 2016 Feb; 37(2):485-92. PubMed ID: 26743688
[TBL] [Abstract] [Full Text] [Related]
2. Positive nin one binding protein expression predicts poor outcome in prostate cancer.
Chen J; Wang J; Cui X; Liu Y; Yin L; Li Y; Chen L; Xu D; Gao Y
Mol Med Rep; 2015 Apr; 11(4):2671-6. PubMed ID: 25503472
[TBL] [Abstract] [Full Text] [Related]
3. Knockdown of NOB1 expression inhibits the malignant transformation of human prostate cancer cells.
Zhang X; Zhang D; Qu F; Hong Y; Cao J; Pan X; Li L; Huang Y; Huang H; Yin L; Chen L; Ren J; Wang Z; Xu D; Cui X
Mol Cell Biochem; 2014 Nov; 396(1-2):1-8. PubMed ID: 25169742
[TBL] [Abstract] [Full Text] [Related]
4. nin one binding protein expression as a prognostic marker in prostate carcinoma.
Liu G; Shen D; Jiao L; Sun Y
Clin Transl Oncol; 2014 Sep; 16(9):843-7. PubMed ID: 24493285
[TBL] [Abstract] [Full Text] [Related]
5. Expression and clinical significance of the nin one binding protein and p38 MAPK in prostate carcinoma.
Che JP; Li W; Yan Y; Liu M; Wang GC; Li QY; Yang B; Yao XD; Zheng JH
Int J Clin Exp Pathol; 2013; 6(11):2300-11. PubMed ID: 24228091
[TBL] [Abstract] [Full Text] [Related]
6. Quantification of extraprostatic perineural spread and its prognostic value in pT3a pN0 M0 R0 prostate cancer patients.
Aumayr K; Breitegger M; Mazal PR; Koller A; Marberger M; Susani M; Haitel A
Prostate; 2011 Dec; 71(16):1790-5. PubMed ID: 21563191
[TBL] [Abstract] [Full Text] [Related]
